• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

NPJ Vaccines . Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines

tetano

Editor, Senior Moderator
NPJ Vaccines


. 2024 Apr 6;9(1):74.
doi: 10.1038/s41541-024-00862-8. Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines

Iván Del Moral-Sánchez[SUP] 1 2 [/SUP], Edmund G Wee[SUP] #[/SUP][SUP] 3 [/SUP], Yuejiao Xian[SUP] #[/SUP][SUP] 4 [/SUP], Wen-Hsin Lee[SUP] 4 [/SUP], Joel D Allen[SUP] 5 [/SUP], Alba Torrents de la Peña[SUP] 4 [/SUP], Rebeca Fróes Rocha[SUP] 4 [/SUP], James Ferguson[SUP] 4 [/SUP], André N León[SUP] 4 [/SUP], Sylvie Koekkoek[SUP] 1 2 [/SUP], Edith E Schermer[SUP] 1 2 [/SUP], Judith A Burger[SUP] 1 2 [/SUP], Sanjeev Kumar[SUP] 1 2 6 [/SUP], Robby Zwolsman[SUP] 1 2 [/SUP], Mitch Brinkkemper[SUP] 1 2 [/SUP], Aafke Aartse[SUP] 1 7 [/SUP], Dirk Eggink[SUP] 1 2 [/SUP], Julianna Han[SUP] 4 [/SUP], Meng Yuan[SUP] 4 [/SUP], Max Crispin[SUP] 5 [/SUP], Gabriel Ozorowski[SUP] 4 [/SUP], Andrew B Ward[SUP] 4 [/SUP], Ian A Wilson[SUP] 4 [/SUP], Tomáš Hanke[SUP] 3 8 [/SUP], Kwinten Sliepen[SUP] 1 2 [/SUP], Rogier W Sanders[SUP] 9 10 11 [/SUP]



Affiliations
Abstract

Recombinant native-like HIV-1 envelope glycoprotein (Env) trimers are used in candidate vaccines aimed at inducing broadly neutralizing antibodies. While state-of-the-art SOSIP or single-chain Env designs can be expressed as native-like trimers, undesired monomers, dimers and malformed trimers that elicit non-neutralizing antibodies are also formed, implying that these designs could benefit from further modifications for gene-based vaccination approaches. Here, we describe the triple tandem trimer (TTT) design, in which three Env protomers are genetically linked in a single open reading frame and express as native-like trimers. Viral vectored Env TTT induced similar neutralization titers but with a higher proportion of trimer-specific responses. The TTT design was also applied to generate influenza hemagglutinin (HA) trimers without the need for trimerization domains. Additionally, we used TTT to generate well-folded chimeric Env and HA trimers that harbor protomers from three different strains. In summary, the TTT design is a useful platform for the design of HIV-1 Env and influenza HA immunogens for a multitude of vaccination strategies.




© 2024. The Author(s).
 
Back
Top Bottom